BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1401769)

  • 1. [Treatment of the pelvis after total pelvic exenteration. Experience of the Regional Paul Strauss Cancer Center of Strasbourg].
    Janser JC; Rodier JF; Rodier D
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(5):527-33. PubMed ID: 1401769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
    Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
    Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal fistulae formation following pelvic exenteration: a review of the University of Texas M. D. Anderson Cancer Center experience, 1957-1990.
    Miller B; Morris M; Gershenson DM; Levenback CL; Burke TW
    Gynecol Oncol; 1995 Feb; 56(2):207-10. PubMed ID: 7896187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urological leaks after pelvic exenterations comparing formation of colonic and ileal conduits.
    Teixeira SC; Ferenschild FT; Solomon MJ; Rodwell L; Harrison JD; Young JM; Vasilaras A; Eisinger D; Lee P; Byrne C
    Eur J Surg Oncol; 2012 Apr; 38(4):361-6. PubMed ID: 22265840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic exenteration. Has it a role in 1987? A six year experience.
    Shepherd JH
    Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic floor reconstruction following gynecologic exenterative surgery.
    Perticucci S
    Obstet Gynecol; 1977 Jul; 50(1):31-4. PubMed ID: 327361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of polyglactin 910 mesh (Vicryl) in pelvic oncologic surgery.
    Rodier JF; Janser JC; Delahaye JF; Rodier D
    Adv Ther; 1992; 9(4):233-9. PubMed ID: 10148112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choices in creating continent urostomies following pelvic exenteration for gynecologic malignancies.
    Silver DF; Ashwell TR
    Gynecol Oncol; 2001 Sep; 82(3):510-5. PubMed ID: 11520148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis.
    Kraybill WG; Lopez MJ; Bricker EM
    Surg Gynecol Obstet; 1988 Mar; 166(3):259-63. PubMed ID: 3344455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the pelvic floor after pelvic exenteration.
    Webb MJ; Symmonds RE
    Obstet Gynecol; 1977 Aug; 50(2):166-71. PubMed ID: 876557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
    Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
    Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic exenteration for primary and recurrent gynaecological malignancies.
    de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low colorectal anastomosis after radical pelvic surgery: a risk factor analysis.
    Mirhashemi R; Averette HE; Estape R; Angioli R; Mahran R; Mendez L; Cantuaria G; Penalver M
    Am J Obstet Gynecol; 2000 Dec; 183(6):1375-9; discussion 1379-80. PubMed ID: 11120499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal fistula and obstruction following pelvic exenteration.
    Lifshitz S; Johnson R; Roberts JA; Buchsbaum HJ
    Surg Gynecol Obstet; 1981 May; 152(5):630-2. PubMed ID: 7221846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current status of frequency and complications of pelvic exenterations for recurrent cervico-uterine cancer after radiation].
    Torres-Lobatón A; González-Mendoza RL; Román-Bassaure E; Hernández-Aten D; Rojo-Herrera G
    Ginecol Obstet Mex; 1996 Dec; 64():538-43. PubMed ID: 9019436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases].
    Zhang Z; Zang R; Chen J
    Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):288-90. PubMed ID: 11775910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a saline breast implant to cover the pelvic floor.
    Van Le L; Fowler WC
    Gynecol Oncol; 1997 Apr; 65(1):188-91. PubMed ID: 9103413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of pelvic exenterations in the treatment of cervix cancers. Apropos of 41 surgically treated cases].
    Janser JC; Rodier JF; Rodier D; Vergnes Y
    Chirurgie; 1994-1995; 120(8):409-14; 414-5. PubMed ID: 7648894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary pelvic exenteration in cervical cancer patients.
    Ungar L; Palfalvi L; Novak Z
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S9-12. PubMed ID: 18775558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic exenteration in gynecologic oncology: Experience at the Mount Sinai Center, 1975-1992.
    Dottino PR; Segna RA; Jennings TS; Mandeli JP; Konsker K; Cohen CJ
    Mt Sinai J Med; 1995 Nov; 62(6):431-5. PubMed ID: 8692157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.